Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis

We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, an...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of tropical medicine and hygiene Vol. 110; no. 6; pp. 1210 - 1213
Main Authors Abanto, Jesus, Sanchez Boluarte, Arantxa N., Castillo, Yesenia, Perez, Erika, Saavedra, Herbert, Gonzales, Isidro, Bustos, Javier A., Abravanel, Florence, Izopet, Jacques, Madden, Richie G., Garcia, Hector H., Dalton, Harry R.
Format Journal Article
LanguageEnglish
Published United States Institute of Tropical Medicine 05.06.2024
American Society of Tropical Medicine and Hygiene
The American Society of Tropical Medicine and Hygiene
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population ( P = 0.023) and 14.4% in subjects with neurological complaints without NCC ( P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients ( P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.
AbstractList We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.
We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population ( P = 0.023) and 14.4% in subjects with neurological complaints without NCC ( P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients ( P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.
We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological referral center in Lima, Perú, between the years 2008 and 2012. Anti-hepatitis E antibodies were evaluated in patients with and without NCC, and a control group of rural general population. Anti-hepatitis E IgG was found in 23.8% of patients with NCC, compared with 14.3% in subjects without NCC from a general rural population (P = 0.023) and 14.4% in subjects with neurological complaints without NCC (P = 0.027). Seropositive patients had a median age of 44 years compared with 30 years in seronegative patients (P <0.001). No significant differences in sex, region of residence, or liver enzyme values were found. Seropositivity to hepatitis E was frequent in this Peruvian population and higher in patients with NCC, suggesting shared common routes of infection.
Author Sanchez Boluarte, Arantxa N.
Castillo, Yesenia
Abravanel, Florence
Bustos, Javier A.
Dalton, Harry R.
Izopet, Jacques
Madden, Richie G.
Abanto, Jesus
Gonzales, Isidro
Garcia, Hector H.
Saavedra, Herbert
Perez, Erika
Author_xml – sequence: 1
  givenname: Jesus
  surname: Abanto
  fullname: Abanto, Jesus
  organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Department of Neurology, University of Cincinnati, Cincinnati, Ohio
– sequence: 2
  givenname: Arantxa N.
  surname: Sanchez Boluarte
  fullname: Sanchez Boluarte, Arantxa N.
  organization: Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú;, Department of Global Health, University of Washington, Seattle, Washington
– sequence: 3
  givenname: Yesenia
  surname: Castillo
  fullname: Castillo, Yesenia
  organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú
– sequence: 4
  givenname: Erika
  surname: Perez
  fullname: Perez, Erika
  organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
– sequence: 5
  givenname: Herbert
  surname: Saavedra
  fullname: Saavedra, Herbert
  organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
– sequence: 6
  givenname: Isidro
  surname: Gonzales
  fullname: Gonzales, Isidro
  organization: Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
– sequence: 7
  givenname: Javier A.
  surname: Bustos
  fullname: Bustos, Javier A.
  organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
– sequence: 8
  givenname: Florence
  surname: Abravanel
  fullname: Abravanel, Florence
  organization: Laboratoire de Virologie, CHU Purpan, Toulouse, France
– sequence: 9
  givenname: Jacques
  surname: Izopet
  fullname: Izopet, Jacques
  organization: Laboratoire de Virologie, CHU Purpan, Toulouse, France
– sequence: 10
  givenname: Richie G.
  surname: Madden
  fullname: Madden, Richie G.
  organization: Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia;, HEV International Direct Action Group (HEViDrAG)
– sequence: 11
  givenname: Hector H.
  surname: Garcia
  fullname: Garcia, Hector H.
  organization: Centro de Salud Global, Universidad Peruana Cayetano Heredia, Lima, Perú;, Centro Básico de Investigación en Exámenes Auxiliares en Parasitosis del Sistema Nervioso Central, Instituto Nacional de Ciencias Neurológicas, Lima, Perú
– sequence: 12
  givenname: Harry R.
  surname: Dalton
  fullname: Dalton, Harry R.
  organization: Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, South Australia;, HEV International Direct Action Group (HEViDrAG)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38653231$$D View this record in MEDLINE/PubMed
https://hal.science/hal-05038015$$DView record in HAL
BookMark eNpdkk1vEzEQhi1URNPCkSuyxIUetnjWnzmhqCpNpQh6AC4cLK9jE0cbO9jeoP57dkmpoKeRZp55ZzTznqGTmKJD6DWQS9aK-XuzrbvNZUsborh4hmbApGhAMH6CZoSQtpkLKk_RWSlbQkC1AC_QKVWC05bCDH2_jTY7U9wa32V3ML2L1uHk8SLW0KV1cAXXhJdub2qooeBr_C3koeAQ8d2YcrEW_CvUDf7khpzsfanBumxTCeUleu5NX9yrh3iOvn68_nK1bFafb26vFqvGMiJqQ5nwjK1NS7g0gqi19Mw7o0ApIyXvaMe5JEKClyC4VN5yTrwFzzvDLDX0HH046u6HbufWdtwpm17vc9iZfK-TCfr_Sgwb_SMdNABwRhgbFS6OCpsnfcvFSk85wglVBPgBRvbdw7Scfg6uVL0Lxbq-N9GloWhKGAeYS5hk3z5Bt2nIcbzFSMlWUUrnE_Xm3_Uf5_990gg0R8DmVEp2_hEBoicT6D8m0C3Vkwnob5ZmpG8
ContentType Journal Article
Copyright Copyright Institute of Tropical Medicine Jun 2024
Distributed under a Creative Commons Attribution 4.0 International License
2024, American Society of Tropical Medicine and Hygiene 2024
Copyright_xml – notice: Copyright Institute of Tropical Medicine Jun 2024
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2024, American Society of Tropical Medicine and Hygiene 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
5PM
DOI 10.4269/ajtmh.23-0856
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-1645
EndPage 1213
ExternalDocumentID PMC11154044
oai_HAL_hal_05038015v1
38653231
10_4269_ajtmh_23_0856
Genre Journal Article
GeographicLocations Peru
GeographicLocations_xml – name: Peru
GrantInformation_xml – fundername: FIC NIH HHS
  grantid: D43 TW001140
GroupedDBID ---
23M
2WC
34G
36B
53G
5GY
5RE
5VS
6J9
AAYXX
ABCQX
ABPPZ
ACGFO
ADBBV
ADTPD
AENEX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
DIK
E3Z
EBD
EBS
EJD
EMB
EMOBN
F5P
GX1
H13
HYE
K-O
KQ8
L7B
MV1
OK1
P2P
PQQKQ
RHI
RPM
SV3
TR2
TST
UPT
W8F
WH7
WOQ
WOW
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
5PM
ID FETCH-LOGICAL-c406t-346f44da2057a608d7f4fea8188a775b3b5570671f716578fc550fc1f5ba4c3a3
ISSN 0002-9637
1476-1645
IngestDate Thu Aug 21 18:36:38 EDT 2025
Fri May 09 12:24:02 EDT 2025
Fri Jul 11 13:04:10 EDT 2025
Sun Jun 29 16:37:55 EDT 2025
Mon Jul 21 06:06:14 EDT 2025
Tue Jul 01 03:04:24 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c406t-346f44da2057a608d7f4fea8188a775b3b5570671f716578fc550fc1f5ba4c3a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC11154044
Disclosure: The authors certify that they have no affiliations with or involvement in any entity with any financial interest.
Authors’ addresses: Jesus Abanto, Department of Neurology, University of Cincinnati, Cincinnati, OH, and Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mail: abantojs@ucmail.uc.edu. Arantxa N. Sanchez Boluarte, Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru, and Department of Global Health, University of Washington, Seattle, WA, E-mail: aransb21@uw.edu. Yesenia Castillo, Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mail: yesenia.castillo.b@upch.pe. Erika Perez, Isidro Gonzales, and Herbert Saavedra, Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru, E-mails: erika.perez.p@upch.pe, isidrogonzalesq@hotmail.com, and hsaavedrapastor@hotmail.com. Javier A. Bustos and Hector H. Garcia, Center for Global Health, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru, and Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru, E-mails: jbustos@jhsph.edu and hgarcia@jhsph.edu. Florence Abravanel and Jacques Izopet, Laboratoire de Virologie, CHU Purpan, Toulouse, France, E-mails: abravanel.f@chu-toulouse.fr and izopet.j@chu-toulouse.fr. Richie G. Madden and Harry R. Dalton, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, University of Adelaide, Australia, and HEV International Direct Action Group, E-mails: richie@forfey.com and hardalton@gmail.com.
Financial support: Beijing Wantai Biological donated the ELISA kits for detection of IgG and IgM antibodies against HEV used in this study. J. Abanto is partially supported by FIC NIH training grant TW001140.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/11154044
PMID 38653231
PQID 3072833394
PQPubID 105381
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11154044
hal_primary_oai_HAL_hal_05038015v1
proquest_miscellaneous_3045119714
proquest_journals_3072833394
pubmed_primary_38653231
crossref_primary_10_4269_ajtmh_23_0856
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-Jun-05
PublicationDateYYYYMMDD 2024-06-05
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-Jun-05
  day: 05
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Deerfield, Illinois
PublicationTitle The American journal of tropical medicine and hygiene
PublicationTitleAlternate Am J Trop Med Hyg
PublicationYear 2024
Publisher Institute of Tropical Medicine
American Society of Tropical Medicine and Hygiene
The American Society of Tropical Medicine and Hygiene
Publisher_xml – name: Institute of Tropical Medicine
– name: American Society of Tropical Medicine and Hygiene
– name: The American Society of Tropical Medicine and Hygiene
References Garcia (b16) 2016; 374
Pischke (b8) 2019; 11
Passos-Castilho (b18) 2017; 21
Mclean (b10) 2017; 17
Chandnani (b21) 2016; 17
Sarda (b22) 2009; 129
Garcia (b15) 2014; 14
(b4) 2023
Rivero-Juarez (b9) 2019; 10
Izopet (b3) 2019; 120
Vildosola (b17) 2000; 20
Garcia (b14) 2014; 55
(b5) 2021
Thom (b6) 2018; 23
Fierro (b12) 2016; 22
Van der Poel (b7) 2018; 65
Garcia (b13) 2016; 62
Wallace (b20) 2017; 29
Campolmi (b19) 2018; 98
Guerra (b1) 2017; 5
Kamar (b2) 2017; 3
Garcia (b11) 2014; 13
References_xml – year: 2023
  ident: b4
– volume: 20
  start-page: 111
  year: 2000
  ident: b17
  article-title: Hepatitis E IgG antibodies seroprevalence in a Peruvian risk group
– volume: 17
  start-page: 584
  year: 2016
  ident: b21
  article-title: A case report about the most common yet most forgotten hepatitis E
– volume: 21
  start-page: 535
  year: 2017
  ident: b18
  article-title: High prevalence of hepatitis E virus antibodies in Sao Paulo, southeastern Brazil: Analysis of a group of blood donors representative of the general population
– volume: 120
  start-page: 20
  year: 2019
  ident: b3
  article-title: Hepatitis E virus infections in Europe
– volume: 129
  start-page: 64
  year: 2009
  ident: b22
  article-title: Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity
– volume: 3
  start-page: 17086
  year: 2017
  ident: b2
  article-title: Hepatitis E virus infection
– volume: 374
  start-page: 2335
  year: 2016
  ident: b16
  article-title: Elimination of Taenia solium transmission in northern Peru
– volume: 98
  start-page: 1275
  year: 2018
  ident: b19
  article-title: Seroprevalence of hepatitis A virus, hepatitis E virus, and Helicobacter pylori in rural communities of the Bolivian Chaco, 2013
– volume: 5
  start-page: 376
  year: 2017
  ident: b1
  article-title: Hepatitis E: A literature review
– volume: 11
  start-page: 186
  year: 2019
  ident: b8
  article-title: Chronic Hepatitis E in rheumatology and internal medicine patients: A retrospective multicenter European cohort study
– volume: 14
  start-page: 687
  year: 2014
  ident: b15
  article-title: Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: A double-blind, randomised controlled trial
– year: 2021
  ident: b5
– volume: 17
  start-page: 282
  year: 2017
  ident: b10
  article-title: Hepatitis E virus and neurological disorders
– volume: 13
  start-page: 1202
  year: 2014
  ident: b11
  article-title: Clinical symptoms, diagnosis, and treatment of neurocysticercosis
– volume: 29
  start-page: 215
  year: 2017
  ident: b20
  article-title: Investigation of liver dysfunction: Who should we test for hepatitis E?
– volume: 22
  start-page: 2271
  year: 2016
  ident: b12
  article-title: Hepatitis E virus: An ancient hidden enemy in Latin America
– volume: 23
  start-page: 17-00174
  year: 2018
  ident: b6
  article-title: Hepatitis E virus (HEV) in Scotland: Evidence of recent increase in viral circulation in humans
– volume: 10
  start-page: 1425
  year: 2019
  ident: b9
  article-title: Hepatitis E infection in HIV-infected patients
– volume: 55
  start-page: 1452
  year: 2014
  ident: b14
  article-title: Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after
– volume: 65
  start-page: 22
  year: 2018
  ident: b7
  article-title: Knowledge gaps and research priorities in the prevention and control of hepatitis E virus infection
– volume: 62
  start-page: 1375
  year: 2016
  ident: b13
  article-title: Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis
SSID ssj0018211
Score 2.4315522
Snippet We explored the association between serological status for hepatitis E and neurocysticercosis (NCC) in neurologic patients attending a national neurological...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1210
SubjectTerms Adolescent
Adult
Aged
Antibodies
Female
Hepatitis
Hepatitis Antibodies
Hepatitis Antibodies - blood
Hepatitis E
Hepatitis E - epidemiology
Hepatitis E - immunology
Hepatitis E virus
Hepatitis E virus - immunology
Humans
Immunoglobulin G
Immunoglobulin G - blood
Life Sciences
Male
Middle Aged
Neurocysticercosis
Neurocysticercosis - complications
Neurocysticercosis - epidemiology
Neurocysticercosis - immunology
Neurological disorders
Patients
Peru
Peru - epidemiology
Prevalence
Seroepidemiologic Studies
Short Report
Young Adult
Title Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis
URI https://www.ncbi.nlm.nih.gov/pubmed/38653231
https://www.proquest.com/docview/3072833394
https://www.proquest.com/docview/3045119714
https://hal.science/hal-05038015
https://pubmed.ncbi.nlm.nih.gov/PMC11154044
Volume 110
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLY6g4S4IHYKAzIIcalSmthZehygqCwzQqKDBnGIbNcmAZGM2hQx87v4gbznpFnaHgYuUZQ4m9_zW_I-fybkGROuVIGJnADchcOVNs5YSOmM5p7yhRKesez6R8fB9IS_O_VPe70_LdTSqpBDdbFzXsn_SBWOgVxxluw_SLa-KRyAfZAvbEHCsL2UjGFwI6ZcI94fabvtKMXQMitSmSM-EEPLqUbUdJEuB5PB53SxsgjYjyWfajW5zVJ0qHO7sNdC5ct02Q5aZ83sk6xNNVEs8jMr43WB3lYikvNvcOdGkyQuU1wCaZarOoL_BNqW6IvBS-gghJVaGwV-s_gtBsfDpjICr1RVh77gPKlUNLZ8Uf78Bkv-Q7R_Xnjcgqz8DYMMNqD0ubq0wTwMHMji_I6RrsCv6ZbJRQa0lvtGirpdrgGn7KLf-178TIYecyDU3EHBveEaa8AipEp4g9heHnssxsv3yBUPkhNcN-P12_d17SryXHeddOGnlcyuePmLztM7kdBegjjc7SRnE6vbCn5mN8j1Kmuhh6UK3iQ9nd0iV48qsd8mX2tNpI0m0tzQRhNpkdNaE-mEWk2kaUbXmkhRE-m2Jt4hJ28ms1dTp1q2w1EQHRYO44HhfC48SAVEMIrmoeFGC4gMIxGGvmQSad-C0DWQq4PDMAqyZKNc40vBFRPsLtnP8kzfJxRMh5TjyPeN4ly7euxKMUYKzZEODWNhnzxfd2F8VrKzxDtF1SdPoYPrNsipPj38EOMxS4gEQfEvt08O1v0fV4NpGYMPhAicsTHvkyf1abDBWFgTmc5X2IbbcrwLbe6V4qofhWvqMkii-iTqCLLzLt0zWZpYnncXqbJGnD-47Fc-JNeaQXZA9ovFSj-CmLmQj62K_gVu4MdT
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Prevalence+of+Antibodies+to+Hepatitis+E+Virus+in+Patients+with+Neurocysticercosis&rft.jtitle=The+American+journal+of+tropical+medicine+and+hygiene&rft.au=Abanto%2C+Jesus&rft.au=Sanchez+Boluarte%2C+Arantxa+N.&rft.au=Castillo%2C+Yesenia&rft.au=Perez%2C+Erika&rft.date=2024-06-05&rft.issn=0002-9637&rft.eissn=1476-1645&rft.volume=110&rft.issue=6&rft.spage=1210&rft.epage=1213&rft_id=info:doi/10.4269%2Fajtmh.23-0856&rft.externalDBID=n%2Fa&rft.externalDocID=10_4269_ajtmh_23_0856
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9637&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9637&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9637&client=summon